Wayrilz 400 MG Oral Tablet

RxCUI
2722409
RxNorm name
Wayrilz 400 MG Oral Tablet
Display name
Wayrilz 400 MG Oral Tablet
Full name
Wayrilz 400 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
WAYRILZRILZABRUTINIBGenzyme Corporation95ffd367-9b0c-4f75-8487-5d8f3c0a5ad02025-08-26Warnings, Adverse reactionsExact identifier
rxcui: 2722409

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0WAYRILZ 400 MG Oral Tablet [PSN] · rilzabrutinib 400 MG Oral Tablet [Wayrilz] [SBD] · Wayrilz 400 MG Oral Tablet [SY]36These highlights do not include all the information needed to use WAYRILZ™ safely and effectively. See full prescribing information for WAYRILZ. WAYRILZ™ (rilzabrutinib) tablets, for oral use Initial U.S. Approval: 202520250826